GlassScriptPhysician profile
Saravjit Singh Bhatti
NPI 1982284824
$1,480.41
in general payments reported to CMS, 2019-2025
9 companies · $748 in 2025
The $748 reported for 2025 was more than what 81% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $115 · 2024: $618 · 2025: $748.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,480.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,480.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $454.48 | 2024-2025 | |
| Janssen Biotech, INC. | $390.06 | 2024-2025 | Tremfya, Simponi Aria |
| Boehringer Ingelheim Pharmaceuticals, INC. | $239.94 | 2023-2025 | |
| Amgen INC. | $117.88 | 2025 | Tavneos |
| Glaxosmithkline, LLC. | $117.88 | 2025 | Benlysta |
| Astellas Pharma US INC | $96.95 | 2024 | Veozah |
| Exact Sciences Corporation | $26.31 | 2024 | Cologuard Collection Kit |
| Cranial Technologies, INC | $18.49 | 2025 | Doc Band |
| Hologic Sales and Service, LLC | $18.42 | 2025 | Thinprep 2000 Processor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saravjit Bhatti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.